118 related articles for article (PubMed ID: 15922295)
1. Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist.
Nakayama M; Inoguchi T; Sonta T; Maeda Y; Sasaki S; Sawada F; Tsubouchi H; Sonoda N; Kobayashi K; Sumimoto H; Nawata H
Biochem Biophys Res Commun; 2005 Jul; 332(4):927-33. PubMed ID: 15922295
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice.
Shao J; Iwashita N; Ikeda F; Ogihara T; Uchida T; Shimizu T; Uchino H; Hirose T; Kawamori R; Watada H
Biochem Biophys Res Commun; 2006 Jun; 344(4):1224-33. PubMed ID: 16650382
[TBL] [Abstract][Full Text] [Related]
4. Candesartan attenuates fatty acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic beta-cells.
Saitoh Y; Hongwei W; Ueno H; Mizuta M; Nakazato M
Diabetes Res Clin Pract; 2010 Oct; 90(1):54-9. PubMed ID: 20667613
[TBL] [Abstract][Full Text] [Related]
5. Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.
Wang P; Tang F; Li R; Zhang H; Chen S; Liu P; Huang H
Pharmacol Res; 2007 May; 55(5):408-17. PubMed ID: 17324585
[TBL] [Abstract][Full Text] [Related]
6. Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice.
Cole BK; Keller SR; Wu R; Carter JD; Nadler JL; Nunemaker CS
Hypertension; 2010 Mar; 55(3):715-21. PubMed ID: 20100990
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice.
Shiuchi T; Iwai M; Li HS; Wu L; Min LJ; Li JM; Okumura M; Cui TX; Horiuchi M
Hypertension; 2004 May; 43(5):1003-10. PubMed ID: 15037562
[TBL] [Abstract][Full Text] [Related]
8. Combination of the dipeptidyl peptidase IV inhibitor LAF237 [(S)-1-[(3-hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the angiotensin II type 1 receptor antagonist valsartan [N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-L-valine] enhances pancreatic islet morphology and function in a mouse model of type 2 diabetes.
Cheng Q; Law PK; de Gasparo M; Leung PS
J Pharmacol Exp Ther; 2008 Dec; 327(3):683-91. PubMed ID: 18787107
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment.
Etoh T; Inoguchi T; Kakimoto M; Sonoda N; Kobayashi K; Kuroda J; Sumimoto H; Nawata H
Diabetologia; 2003 Oct; 46(10):1428-37. PubMed ID: 13680125
[TBL] [Abstract][Full Text] [Related]
10. Protection against oxidative stress in diabetic rats: role of angiotensin AT(1) receptor and beta 1-adrenoceptor antagonism.
Dorenkamp M; Riad A; Stiehl S; Spillmann F; Westermann D; Du J; Pauschinger M; Noutsias M; Adams V; Schultheiss HP; Tschöpe C
Eur J Pharmacol; 2005 Sep; 520(1-3):179-87. PubMed ID: 16139267
[TBL] [Abstract][Full Text] [Related]
11. The synergistic effect of valsartan and LAF237 [(S)-1-[(3-hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] on vascular oxidative stress and inflammation in type 2 diabetic mice.
Shen M; Sun D; Li W; Liu B; Wang S; Zhang Z; Cao F
Exp Diabetes Res; 2012; 2012():146194. PubMed ID: 22474415
[TBL] [Abstract][Full Text] [Related]
12. Valsartan attenuates oxidative stress and NF-κB activation and reduces myocardial apoptosis after ischemia and reperfusion.
Wu B; Lin R; Dai R; Chen C; Wu H; Hong M
Eur J Pharmacol; 2013 Apr; 705(1-3):140-7. PubMed ID: 23499691
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin II type 1 receptor blocker on albumin-induced cell damage in human renal proximal tubular epithelial cells.
Takao T; Horino T; Kagawa T; Matsumoto R; Inoue K; Taguchi T; Morita T; Iwasaki Y; Hashimoto K; Terada Y
Am J Nephrol; 2009; 29(2):102-8. PubMed ID: 18689996
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II Type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young Type 2 diabetic mice.
Chu KY; Leung PS
Antioxid Redox Signal; 2007 Jul; 9(7):869-78. PubMed ID: 17508912
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts.
Hotta H; Miura T; Miki T; Togashi N; Maeda T; Kim SJ; Tanno M; Yano T; Kuno A; Itoh T; Satoh T; Terashima Y; Ishikawa S; Shimamoto K
Circ Res; 2010 Jan; 106(1):129-32. PubMed ID: 19910577
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan attenuates fatty-acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic beta-cells.
Saitoh Y; Hongwei W; Ueno H; Mizuta M; Nakazato M
Diabetes Metab; 2009 Nov; 35(5):392-7. PubMed ID: 19713141
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor-mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin-resistant rats.
Vázquez-Medina JP; Popovich I; Thorwald MA; Viscarra JA; Rodriguez R; Sonanez-Organis JG; Lam L; Peti-Peterdi J; Nakano D; Nishiyama A; Ortiz RM
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H599-607. PubMed ID: 23771688
[TBL] [Abstract][Full Text] [Related]
18. Vascular NAD(P)H oxidase mediates endothelial dysfunction in basilar arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
Matsumoto T; Kobayashi T; Wachi H; Seyama Y; Kamata K
Atherosclerosis; 2007 May; 192(1):15-24. PubMed ID: 16831440
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
Whaley-Connell A; Govindarajan G; Habibi J; Hayden MR; Cooper SA; Wei Y; Ma L; Qazi M; Link D; Karuparthi PR; Stump C; Ferrario C; Sowers JR
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E355-63. PubMed ID: 17440033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
